
Dietary supplements are products that are used to supplement the diet which may be useful in taking care of a disease or staying healthy.
- Dietary and herbal supplements. National Center for Complementary and Integrative Health. https://www.nccih.nih.gov/health/dietary-and-herbal-supplements. Published February 2020. Accessed September 10, 2021.
- Center for Food Safety and Applied Nutrition. Questions and answers on dietary supplements. U.S. Food and Drug Administration. https://www.fda.gov/food/information-consumers-using-dietary-supplements/questions-and-answers-dietary-supplements. Published July 22, 2019. Accessed September 10, 2021.
- Ravindran AV, Balneaves LG, Faulkner G, et al: Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 5. Complementary and alternative medicine treatments. Can J Psychiatry. 2016;61:576–587.
- Nierenberg AA, Lund HG, Mischoulon D: St. John’s wort: a critical evaluation of the evidence of antidepressant effects. Natural Medications for Psychiatry: Considering the Alternatives. 2008;27-29.
- Moore LB, Goodwin B, Jones SA, et al. St. John’s wort induces hepatic drug metabolism through activation of the pregnant X receptor. Proc Natl Acad Sci USA. 2000; 97:7500–7502
- Miller LG. Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med. 1998; 158:2200–2211
- Davis SA, Feldman SR, Taylor SL. Use of St. John’s wort in potentially dangerous combinations. J Altern Complement Med. 2014; 20:578–579
- Sack RL, Hughes RJ, Edgar DM, et al. Sleep-Promoting effects of Melatonin: At what dose, In Whom, under what conditions, and by What Mechanisms? Sleep. 1997;20(10):908-915.
- Arendt J. Jet-Lag and SHIFT Work: (2) therapeutic use of melatonin. Journal of the Royal Society of Medicine. 1999;92(8):402-405.
- Dollins AB, Lynch HJ, Wurtman RJ, et al. Effect of pharmacological daytime doses of melatonin on human mood and performance. Psychopharmacology. 1993;112(4):490-496.
- Partonen T: Melatonin-dependent infertility. Med Hypotheses. 1999; 52:269–270
- Freeman MP, Fava M, Lake J, et al. Complementary and alternative medicine in major depressive disorder: the American Psychiatric Association Task Force report. J Clin Psychiatry. 2010; 71:669–681
- Smith K, Leiras C. The effectiveness and safety of Kava kava for treating anxiety symptoms: a systematic review and analysis of randomized clinical trials. Complement Ther Clin Pract. 2018; 33:107–117
- Ooi SL, Henderson P, Pak SC. Kava for generalized anxiety disorder: a review of current evidence. J Altern Complement Med. 2018; 24:770–780
- White CM. The pharmacology, pharmacokinetics, efficacy, and adverse events associated with kava. J Clin Pharmacol. 2018; 58:1396–1405
- Mei N, Guo X, Ren Z, et al. Review of Ginkgo biloba-induced toxicity, from experimental studies to human case reports. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2017; 35:1–28
- Diamond BJ, Bailey MR. Ginkgo biloba: indications, mechanisms, and safety. Psychiatr Clin North Am. 2013;36:73–83
- Bezchlibnyk-Butler KZ, Jeffries JJ, Virani AS. Clinical handbook of psychotropic drugs. 17th ed. Hogrefe & Huber; 2007.